130 related articles for article (PubMed ID: 33015795)
1. LncRNA WTAPP1 promotes proliferation of laryngeal carcinoma cells through regulating microRNA-592.
Shi XY; Lin JJ; Ge XJ; Shi Y
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9532-9540. PubMed ID: 33015795
[TBL] [Abstract][Full Text] [Related]
2. LncRNA SNHG20 promotes the development of laryngeal squamous cell carcinoma by regulating miR-140.
Li Y; Xu J; Guo YN; Yang BB
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3401-3409. PubMed ID: 31081112
[TBL] [Abstract][Full Text] [Related]
3. LncRNA SNHG14 promotes proliferation of endometrial cancer through regulating microRNA-655-3p.
Wang GF; Wen LN
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10410-10418. PubMed ID: 33155197
[TBL] [Abstract][Full Text] [Related]
4. LncRNA TP73-AS1 promotes malignant progression of hepatoma by regulating microRNA-103.
Ma CX; Gao WC; Tian L
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4713-4722. PubMed ID: 31210297
[TBL] [Abstract][Full Text] [Related]
5. LncRNA LINP1 promotes malignant progression of pancreatic cancer by adsorbing microRNA-491-3p.
Chen AY; Zhang K; Liu GQ
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9315-9324. PubMed ID: 33015772
[TBL] [Abstract][Full Text] [Related]
6. LncRNA UNC5B-AS1 promotes malignant progression of prostate cancer by competitive binding to caspase-9.
Tan SF; Ni JX; Xiong H
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2271-2280. PubMed ID: 32196578
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
Xu L; Hou TJ; Yang P
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
[TBL] [Abstract][Full Text] [Related]
8. LncRNA FAL1 promotes the development of oral squamous cell carcinoma through regulating the microRNA-761/CRKL pathway.
Ye J; Jiao Y
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5779-5786. PubMed ID: 31298329
[TBL] [Abstract][Full Text] [Related]
9. LINC00657 promotes malignant progression of oral squamous cell carcinoma via regulating microRNA-150.
Xu FY; Xu X; Hu XD
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2482-2490. PubMed ID: 32196599
[TBL] [Abstract][Full Text] [Related]
10. LncRNA MINCR promotes the development of liver cancer by regulating microRNA-107/β-catenin.
Li H; Yuan R; Wang H; Li C; Wei J
J BUON; 2020; 25(2):972-980. PubMed ID: 32521894
[TBL] [Abstract][Full Text] [Related]
11. LncRNA TRERNA1 promotes malignant progression of NSCLC through targeting FOXL1.
Luo DB; Lv HB; Sun XH; Wang Y; Chu JH; Salai AL
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1233-1242. PubMed ID: 32096153
[TBL] [Abstract][Full Text] [Related]
12. LncRNA DARS-AS1 regulates microRNA-129 to promote malignant progression of thyroid cancer.
Zheng W; Tian X; Cai L; Shen YM; Cao QS; Yang JY; Tian GY
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10443-10452. PubMed ID: 31841198
[TBL] [Abstract][Full Text] [Related]
13. LncRNA XIST promotes migration of Wilms' tumor cells through modulation of microRNA-193a-5p.
Yao FZ; He R; Jiang YC; Hou Y; Qian D
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9889-9898. PubMed ID: 33090392
[TBL] [Abstract][Full Text] [Related]
14. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
[TBL] [Abstract][Full Text] [Related]
15. LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186.
Luo X; Song Y; Tang L; Sun DH; Ji DG
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7788-7797. PubMed ID: 30536320
[TBL] [Abstract][Full Text] [Related]
16. LINC01551 promotes metastasis of nasopharyngeal carcinoma through targeting microRNA-132-5p.
Xue MY; Cao HX
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3724-3733. PubMed ID: 32329849
[TBL] [Abstract][Full Text] [Related]
17. LncRNA HOTAIR promotes colon cancer development by down-regulating miRNA-34a.
Peng CL; Zhao XJ; Wei CC; Wu JW
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5752-5761. PubMed ID: 31298326
[TBL] [Abstract][Full Text] [Related]
18. LncRNA WTAPP1 promotes cancer cell invasion and migration in NSCLC by downregulating lncRNA HAND2-AS1.
Zhang L; Jin C; Yang G; Wang B; Hua P; Zhang Y
BMC Pulm Med; 2020 May; 20(1):153. PubMed ID: 32473628
[TBL] [Abstract][Full Text] [Related]
19. LncRNA GIHCG regulates microRNA-1281 and promotes malignant progression of breast cancer.
Fan LY; Shi KY; Xu D; Ren LP; Yang P; Zhang L; Wang F; Shao GL
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10842-10850. PubMed ID: 31858553
[TBL] [Abstract][Full Text] [Related]
20. LncRNA ITGB1 promotes the development of bladder cancer through regulating microRNA-10a expression.
Dai L; Chai CM; Shen TY; Tian Y; Shang ZQ; Niu YJ
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6858-6867. PubMed ID: 31486485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
